Inventor · disambiguated record
Reynald Michael Lescarbeau
Also filed as: LESCARBEAU REYNALD · LESCARBEAU REYNALD MICHAEL
5 granted patents·11 pending applications·5 citations·filing 2016–2024
71Inventor score
Top patents by PatentIndex Score
16 records- 0189US11795460B2Compositions and methods for TTR gene editing and treating ATTR amyloidosisINTELLIA THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·24 claims
- 0283US12037583B2Compositions and methods for immunooncologyNOVARTIS AG·Filed 2016·Granted Jul 16, 2024·2 cites·55 claims
- 0383US11549107B2Compositions and methods for treating alpha-1 antitrypsin deficiencyINTELLIA THERAPEUTICS INC·Filed 2019·Granted Jan 10, 2023·2 cites·21 claims
- 0481US2025207130A1Compositions and Methods for TTR Gene Editing and Treating ATTR AmyloidosisINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0577US11965165B2Compositions and methods for TTR gene editing and treating ATTR amyloidosisINTELLIA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·21 claims
- 0673US12460205B2Compositions and methods for treating alpha-1 antitrypsin deficiencyINTELLIA THERAPEUTICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·18 claims
- 0771US2024417722A1Compositions and methods for immunooncologyNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0871US2024124897A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0966US2024002843A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2022·Application pending·0 cites
- 1063US2020248180A1Compositions and Methods for TTR Gene Editing and Treating ATTR AmyloidosisINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1162US2023044994A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1262US2024024478A1Compositions and Methods for Reducing HLA-A in a CellINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1355US2023035659A1Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use ThereofINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1455US2021163943A1Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)INTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1553US2021087568A1Modified Guide RNAs for Gene EditingINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1642US2019010495A1Compositions and methods for the treatment of hemoglobinopathiesNOVARTIS AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Reynald Michael Lescarbeau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →